OLX-301D

N/A

Report date: 2022/12/07 14:39:11
NME

Base Information

Drug NameOLX-301D
Drug Alias NameOLX-301D
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interference
TargetsUpdating
Therapy Area/IndicationsWet age-related macular degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOlix Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesLaboratoires Thea SASThéa Open InnovationOlix Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsWet age-related macular degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A